Capricor Therapeutics Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues to Invest in RD EVER Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Sylvamo Corporation SLVM Q1 2026 Earnings Heavy EPS Miss Weighs on Investor Sentiment Lifevantage Corporation LFVN Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction NIQ Q1 2026 Earnings EPS Beats Estimates by 476 Amid Strong Operational Execution CHCT Q1 2026 Earnings EPS Surges Past Estimates with 449 Beat